共 114 条
[1]
Nordlinger B(2013)Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial Lancet Oncol 14 1208-1215
[2]
Sorbye H(2004)Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 644-657
[3]
Glimelius B(2015)Challenges in the multidisciplinary management of stage IV colon and rectal cancer Expert Rev Gastroenterol Hepatol 9 317-326
[4]
Poston GJ(2018)Conversion to resection in patients receiving systemic chemotherapy for unresectable and/or metastatic colorectal cancer-predictive factors and prognosis Clin Colorectal Cancer 17 e91-e97
[5]
Schlag PM(2014)Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer Ann Oncol 25 1346-1355
[6]
Rougier P(2018)Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3 Eur J Cancer 88 77-86
[7]
Bechstein WO(2019)Multidisciplinary approach of liver metastases from colorectal cancer Ann Gastroenterol Surg 3 50-56
[8]
Primrose JN(2018)Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS Ann Oncol 29 44-70
[9]
Walpole ET(2013)Neoadjuvant chemotherapy can improve outcome of colorectal cancer patients with unresectable metastasis Int J Color Dis 28 1359-1365
[10]
Finch-Jones M(2015)Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis Int J Clin Oncol 20 1140-1146